Policy & Position Statements

AIM has issued a statement expressing concern over ACIP's hepatitis B vaccine recommendations.

AIM submitted public comment in November to the Advisory Committee on Immunization Practices (ACIP).

Vaccines have saved millions of lives and kept millions of families from the devastation of losing a child or loved one to preventable illness.

We support and honor all our CDC colleagues now dealing with the aftermath of this horrific event.

AIM submits statement in support of maintaining a stringent, science-based process for ACIP.

AIM submitted public comment for the May 22, 2025, meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC).

AIM submitted public comment for the April 15-16, 2025, meeting of the Advisory Committee on Immunization Practices (ACIP).

AIM's testimony to the House Subcommittee on Labor, HHS, Education, and Related Agencies regarding funding for the Section 317 Immunization Program.

AIM released a statement on the Biden Administration’s Bridge Access Program For COVID-19 Vaccines and Treatments to Maintain Access to COVID-19 Care for the Uninsured.